Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Context Therapeutics Inc. (CNTX) had Stock-Based Compensation of $0.68M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-8.83M |
|
-- |
|
-- |
|
$9.76M |
|
$-9.76M |
|
$0.93M |
|
$-8.83M |
|
$-8.83M |
|
$-8.83M |
|
$-8.83M |
|
$-8.83M |
|
$-8.83M |
|
$-9.76M |
|
$-9.75M |
|
95.19M |
|
95.19M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$86.95M |
|
$0.04M |
|
$0.20M |
|
$87.15M |
|
$4.56M |
|
-- |
|
$0.05M |
|
$4.61M |
|
$82.54M |
|
$82.54M |
|
$82.54M |
|
89.70M |
|
| Cash Flow Statement Financials | |
$-10.86M |
|
$-0.03M |
|
$-0.02M |
|
$94.43M |
|
$83.52M |
|
$-10.91M |
|
|
Stock-Based Compensation |
$0.68M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.90M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.69% |
|
-10.69% |
|
-10.13% |
|
-10.69% |
|
$0.92 |
|
$-0.11 |
|
$-0.11 |
|